Skip to content
Axcess News – Lifestyle
Author:
CervoMed Inc.
CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies
April 22, 2026
CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting
April 7, 2026
CervoMed Announces Presentations at Upcoming AD/PD™ 2026 Scientific Conference
March 12, 2026